C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2001
11/21/2001	CN1075062C 乙酸衍生物 Acetic acid derivatives
11/21/2001	CN1075061C Heterocyclylbenzonitriles
11/21/2001	CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides
11/20/2001	US6320059 Reacting n-(1-chloro-1-(perfluoroalkyl)methyl)arylimidoyl chloride compound with dieneophile compound or substituted haloethane compound, and base, in presence of solvent
11/20/2001	US6319939 Retinoic acid mimetic anlides
11/20/2001	US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/18/2001	CA2347898A1 Compounds with electron donor and electron acceptor functionality
11/15/2001	WO2001085720A1 Novel anti-infectives
11/15/2001	WO2001085694A2 Substituted diamide derivatives useful as motilin antagonists
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085684A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide
11/15/2001	WO2001085683A2 Pyrrolyl-, furanyl- and thienyl-substituted p-aminophenols and colorants containing said compounds
11/15/2001	WO2001085682A1 Method for processing pyrollidone and n-vinyl pyrollidone residues
11/15/2001	WO2001085680A2 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
11/15/2001	WO2001085675A2 Fluorous tagging compounds and their use
11/15/2001	WO2001085144A2 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
11/15/2001	WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001	WO2000071507A3 INHIBITORS OF FACTOR Xa
11/15/2001	US20010041735 Amino ceramide - like compounds and therapeutic methods of use
11/15/2001	US20010041734 Administering nefiracetam
11/15/2001	US20010041729 Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041705 Heterocyclic carboxamides
11/15/2001	US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001	DE10022988A1 Working-up of pyrrolidone and N-vinylpyrrolidone production residues (e.g. from sump) is effected by thermolysis to give increased yields
11/15/2001	DE10022466A1 Removal of organic impurities from crude alpha-olefin product, from a Fischer-Tropsch process, by extractive distillation using a wash agent containing N-methyl-2-pyrrolidone
11/15/2001	CA2408288A1 Novel substituted diamine derivatives useful as motilin antagonists
11/15/2001	CA2408095A1 Fluorous tagging compounds and their use
11/15/2001	CA2334827A1 Trypsin substrate and diagnostic device, and method of using same
11/14/2001	EP1153917A1 p-Aminophenol derivatives and colorants containing them
11/14/2001	EP1153010A1 $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME
11/14/2001	EP1153006A1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
11/14/2001	CN1322195A Substituted pyrroldinone, thizolidinone or oxazolidinone as herbicides
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/13/2001	US6316636 Synthesis of fluorocarbon compounds
11/13/2001	US6316489 Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
11/13/2001	US6316488 Antibiotic compound
11/13/2001	US6316486 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/13/2001	US6316475 Treatment of cancer, asthma, heart diseases, seizures, inflammation
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316450 Compounds
11/08/2001	WO2001084234A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/08/2001	WO2001083571A2 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001	WO2001083455A1 Process for the preparation of sterically hindered aryloxyamines
11/08/2001	WO2001083447A2 A halopyrrole ligand for use in a catalyst system
11/08/2001	WO2001083446A1 Efficient lactam synthesis
11/08/2001	WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001	WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001	WO2001040180A3 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
11/08/2001	WO2001028997A3 Synthesis of 4-substituted pyrrole-2-carbaldehyde compounds
11/08/2001	US20010039315 For addition polymerization; forming a polymer with alkoxyamine end groups that can be used in a two-stage process for making block polymers; narrow polydispersity and high monomer to polymer conversion ratio
11/08/2001	US20010039280 Optically active 3-[(2-Piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT 1D receptor selective antagonists
11/08/2001	US20010039279 Diamide compounds and compositions containing the same
11/08/2001	DE10021193A1 Verfahren zur Herstellung cyclischer Lactame A process for preparing cyclic lactams
11/08/2001	CA2407692A1 Catalysts containing n-pyrrolyl substituted nitrogen donors
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407195A1 Process for the preparation of sterically hindered aryloxyamines
11/08/2001	CA2405832A1 P-(sulfonyl)aryl and heteroaryls
11/08/2001	CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001	EP1151996A2 Process for the preparation of N,N'-carbonyl-bis-lactames
11/07/2001	EP1151994A1 Succinimide-acid compounds and derivatives thereof
11/07/2001	EP1151993A1 Cyclic amine derivatives and uses thereof
11/07/2001	EP1150997A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
11/07/2001	EP1150996A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/07/2001	EP1150951A1 3-substituted pyrrolidines useful as inhibitors of matrix metallo-proteinases
11/07/2001	EP1150950A2 Anthranilic acid derivatives
11/07/2001	EP1150944A1 N2-phenylamidine derivatives
11/07/2001	EP1150674A1 Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation
11/07/2001	EP1150648A2 Use of water-soluble/dispersible reactive derivatives of polyimido compounds for modifying proteinaceous substrates
11/07/2001	EP0848705B1 Crystalline r-(r,r)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
11/07/2001	EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
11/07/2001	EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	US6313349 Electroluminescent intermediate
11/06/2001	US6313314 Reacting 4-acetamidobenzenesulfonyl halide compound with azide; deblocking, deacetylation; solvent extraction; dehydration with acetic anhydride and metal acetate; cyclization, imidation
11/06/2001	US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants
11/06/2001	US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001	US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/06/2001	US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001	US6313117 Succinate derivative compounds useful as cysteine protease inhibitors
11/06/2001	US6312853 Electrochemical cells with cationic polymers and electroactive sulfur compounds
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders
11/01/2001	US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001	US20010036984 Multifunctional imine-esters as novel crosslinkers for surface coatings
11/01/2001	US20010036926 Compound containing a labile disulfide bond
11/01/2001	CA2407663A1 Inhibitors of dipeptidyl peptidase iv
10/2001
10/31/2001	EP1149118A1 Method of producing derivatized polymers
10/31/2001	EP1149098A1 An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
10/31/2001	EP1149069A1 Phenylglycine derivatives
10/31/2001	EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001	DE10020861A1 Preventing premature polymerization of compounds with O- or N-vinyl groups using alkali(ne earth) metal alcoholates optionally in the form of novel polymerizable vinyl compounds
10/31/2001	DE10008089A1 Production of tubulysin compounds comprises multi-stage process including condensation of N-methylpipecolinoyl-isoleucine with substituted thiazole-4-carboxylic acid derivative
10/31/2001	CN1320130A Polymerization of olefins
10/31/2001	CN1320117A 2-substituted heterocyclic sulfonamides
10/31/2001	CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001	CN1320028A Method of treating hair loss using sulfonamides
10/31/2001	CN1319599A Process for preparing imidazolinone

1 ... 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 ... 404